Monitor for upcoming clinical data readouts or regulatory decisions; the strong passive inflows may reflect positioning for a potential rebound, while quant outflows suggest risk-off behavior or model-driven exits.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Mar 27 $16.97entry
- T+1 · 8mo ago +0.71%α +1.06% · $17.09
- T+5 · 8mo ago +139.42%α +135.56% · $40.63
- T+20 · 7mo ago +141.31%α +128.57% · $40.95
- T+60 · due 5mo ago Pending
How similar events traded
Executive Summary
In Q4 2024, Apellis Pharmaceuticals (APLS) saw a mixed institutional cluster: two mega-passive firms (UBS and Morgan Stanley) significantly increased holdings by $282.5M, while three institutions (Wells Fargo, RenTech, Citadel) reduced positions by $8.8M. The divergence suggests conflicting views on valuation or upcoming catalysts.
Key Financial Metrics
Institutional Positions
Net institutional flow: $273.7M
▲ Buyers (2)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| UBS | DOUBLED | +688.2% | $82.5M | $73.1M |
| Morgan Stanley | DOUBLED | +184% | $307.2M | $209.4M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Wells Fargo | NEAR_EXIT | -96% | $4.0M | -$3.8M |
| RenTech | TRIM | -27% | $10.7M | -$2.1M |
| Citadel | TRIM | -27.2% | $15.1M | -$2.9M |
Key Facts
- UBS doubled its position in APLS, increasing value by $73.1M (+688.2% in shares).
- Morgan Stanley added $209.4M to its position, increasing shares by 184%.
- Wells Fargo nearly exited, reducing its stake by 96% (-$3.8M in value).
- Quant funds RenTech and Citadel each trimmed positions by ~27% (-$5.0M combined).
- Total institutional buying: $282.5M; total selling: $8.8M.
Financial Impact
2 institutions accumulated $282.5M in new/expanded positions while 3 reduced holdings by $8.8M
Risk Factors
- Heavy selling by quant funds could indicate technical or momentum-based deterioration.
- Near-complete exit by Wells Fargo may reflect fundamental concerns or portfolio rebalancing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-APLS-2024-Q4 |
Track record
5 reports on APLS
The track record builds as more bullish or bearish reports settle.
Filters
- May 26, 202624w ago 15-12G Neutral 6/10 No price data
- May 14, 202626w ago 25-NSE Neutral 2/10 Entry $41.03 to $41.03 · 0.00% +1.23% vs SPY
- May 14, 202626w ago 8-K Bullish 8/10 Entry $41.03 to $41.03 · 0.00% +1.23% vs SPY
- May 4, 202628w ago 8-K Neutral 2/10 Entry $40.97 to $40.97 · 0.00% −0.80% vs SPY
- Mar 27, 202633w ago Institutional Cluster Mixed 6/10 Viewing Entry $16.97 to $17.09 ▲ +0.71% +1.06% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers